In addition, pentadecanoic acid acted as a novel histone deacetylase 6 (HDAC6) inhibitor, and it promoted the acetylation of α-tubulin in MCF-7 breast and A549 lung cancer cells dose-dependently (36). This evidence concerns the gene HDAC6 and lung carcinoma.